Article
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
Cancer - 1 Nov 2014
Ulrich Cornelia M, Rankin Cathryn, Toriola Adetunji T, Makar Karen W, Altug-Teber Özge, Benedetti Jacqueline K, Holmes Rebecca S, Smalley Stephen R, Blanke Charles D, Lenz Heinz-Josef
Abstract excerpt
BACKGROUND: Recurrence and toxicity occur commonly among patients with rectal cancer who are treated with 5-fluorouracil (5-FU). The authors hypothesized that genetic variation in folate-metabolizing genes could play a role in interindividual variability. The objective of the current study was to evaluate the associations between genetic variants in folate-metabolizing genes and clinical outcomes among patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
